PEER REVIEW COMMITTEE

In order to achieve the goal of distributing the samples from the Biorepository to investigators globally whose later-stage research targets shortening treatment times for TB drugs or identify biomarkers, the CTB2 developed a formal Peer Review Process.  The Peer Review Process will be managed by a Peer Review Committee (PRC), a self-governed Committee which reports to the CTB2 and is dedicated to serving the goals of the Biorepository. 

 

The PRC includes formal procedures for review of applications for samples from the Biorepository. Current Committee members are listed below.  While members are listed, please direct contact to the Permanent Secretary or the address in the Application Process section.

 

Peer Review Committee Members and Their Affiliations
Sufian Al Khaldi*, Senior Scientific Advisor, FDA
Connie Benson, TB Clinical and Basic Research, ACTG
Lei Fang, Biostatistician, Independent
Jennifer Gardiner*, Biomarker Research,BMGF
Judith Giri, Biorepository, Independent
Daniella Livnat*, Infectious Disease, NIAID
Stephen Murray, TB Clinical and Basic Research, TB Alliance
Payam Nahid, TB Clinical and Basic Research, TBTC
Gerhard Walzl, TB Basic Research, Independent
Frank Weichold, Critical Path and Regulatory Science, FDA
Connie Moreadith*, Permanent Secretary, Independent

                                                                                           

Click to learn more about how to obtain samples through Biospecimen Access.

* Non-voting member